January 1 was more than just the start of a new year for USP in 2018. It was the implementation date of two new standards designed to safeguard the global drug supply from potentially toxic impurities – mercury, cadmium, arsenic, and lead, for example.

For patients needing a bone marrow or stem cell transplant, successful treatment often depends on finding a viable transplant sample with the right amount of hematopoietic stem cells (HSCs) to rebuild the patient’s immune system.

The threat of food fraud is a growing concern because increasingly complex global food supply chains create numerous opportunities for fraudsters. This article discusses the challenges faced by stakeholders, and how to prevent these issues before they arise.

There’s something about an anniversary that inspires me to look to the future as well as appreciate the past, especially at the start of a new year. As we mark the anniversary of the 10th year of USP-China, the future and the past offer a great deal to appreciate.

In Nigeria, mothers frequently deliver their babies at home—only 36 percent deliver at health care facilities. Giving birth without the assistance of trained healthcare providers leaves babies vulnerable to infections, and some can be fatal.

In conversations about the role of quality standards in public health, you might come across the words “compendia” and “compendial.” At USP, terms like “compendial approaches,” “compendial standards,” and “compendial tools” are part of our everyday vocabulary.